Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

This tool combines scientometric methods and ‘density equalizing mapping projections’ (DEMP ... In this study, we applied this concept to the RSV-specific research productivity of single countries and ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...

The National Notifiable Diseases Surveillance System recorded 175,786 cases of respiratory syncytial virus in 2024. It is the highest number of cases recorded since the virus became notifiable.

Influenza, or the flu, is a contagious respiratory virus. It can be a severe illness that affects the nose, throat and sometimes lungs. Symptoms of influenza are sore throat, cough, congestion ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and Prevention. But there's a fourth "bug" the public should be aware of: respiratory ...

Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...

Winter is usually accompanied by an uptick in respiratory illnesses, such as Covid-19 and RSV, and 2025 is no exception. For RSV in particular, nearly two dozen states are currently reporting high ...

It's flu season. And COVID season. And RSV season. The Centers for Disease Control and Prevention (CDC) reported that as of last week, "the amount of acute respiratory illness causing people to ...